Brazil's EMS acquires Medley for R$3.6 billion, targets US market after 2030 - Generics and Biosimilars Initiative
HealthcarePlatform
EMS→Medley
May 6, 2026
Pharmacy M&A Deals
135 dealsTrack pharmacy acquisitions and investments within the healthcare sector.
CoreCivic, Inc. — SEC 8-K Filing
HealthcareTennesseeAdd-on
CoreCivic→Clinical Solutions Pharmacy
May 6, 2026
C - Chiesi Farmaceutici SpA (0001464415) (Filed by) — SEC SC TO Filing
HealthcareMerger
Chiesi Farmaceutici→KalVista Pharmaceuticals
May 5, 2026
C - KalVista Pharmaceuticals, Inc. (0001348911) (Subject) — SEC SC TO Filing
HealthcareMassachusettsMerger
Chiesi Farmaceutici→KalVista Pharmaceuticals
May 5, 2026
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
HealthcareMerger
Phoenix Asia Holdings→ACEA Pharma
May 5, 2026
TopGum Completes U.S. Acquisition of PL Developments’ Gummy Operations in Up to $35 Million Deal - citybiz
HealthcareNew YorkAdd-on
TopGum→P&L Developments
May 5, 2026
Scilex Holding Co (SCLX, SCLXW) — SEC 8-K Filing
HealthcareCaliforniaPlatform
Phoenix Asia Holdings→ACEA Pharma
May 5, 2026
A $300M biotech merger gives Gyre a China drug business and new CEO - Stock Titan
HealthcareCaliforniaMerger
Gyre Therapeutics→Cullgen
May 4, 2026
UCB To Acquire Candid Therapeutics For Up To $2.2 Billion - Pulse 2.0
HealthcarePlatform
UCB→Candid Therapeutics
May 4, 2026
PharmaCorp Completes Acquisition of Pharmacy Files in Western Canada
HealthcareAdd-on
PharmaCorp Rx
May 1, 2026
Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
HealthcareMerger
Sun Pharma→Organon
May 1, 2026
PharmaCorp to Acquire Eight Pharmacies and Provides Acquisition Pipeline Update
HealthcareAdd-on
PharmaCorp Rx→PharmaChoice Canada pharmacies
Apr 30, 2026
Avalyn, in pursuit of better lung drugs, banks $300M in an IPO
HealthcareMassachusettsOther
Avalyn Pharma
Apr 30, 2026
Avalyn Announces Pricing of Upsized Initial Public Offering
HealthcareNew YorkOther
Avalyn Pharma
Apr 30, 2026
Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition
HealthcareAdd-on
Chiesi Group→KalVista Pharmaceuticals
Apr 29, 2026
Chiesi to buy KalVista in $1.9B deal for rare disease drug
HealthcarePlatform
Chiesi→KalVista Pharmaceuticals
Apr 29, 2026
Chiesi Group To Acquire KalVista Pharmaceuticals For $1.9 Billion To Expand Rare Disease Portfolio - Pulse 2.0
HealthcarePlatform
Chiesi Group→KalVista Pharmaceuticals
Apr 29, 2026
Chiesi, $1.9 billion deal to acquire KalVista - Il Sole 24 ORE
HealthcareNew YorkMerger
Chiesi→KalVista Pharmaceuticals
Apr 29, 2026
Teva acquires Emalex Biosciences for up to $900m - Globes - Israel Business News
HealthcareMerger
Teva→Emalex Biosciences
Apr 29, 2026
Teva (TEVA) Announces Acquisition of Emalex Biosciences - GuruFocus
HealthcareNew JerseyMerger
Teva→Emalex Biosciences
Apr 29, 2026